Reconciled ClinicalTrials.gov v2 Protocol Specification
| Protocol Field | Verified Registry Value |
|---|---|
| NCT Identifier | NCT07819435 |
| Consolidated Lead Sponsor | Pelage Pharmaceuticals |
| Therapeutic Condition Cohort | Immunology, Rheumatology, and Dermatology |
| Clinical Trial Phase | Phase II/III |
| Overall Recruitment Status | RECRUITING |
| Registered Enrollment | 600 participants (ESTIMATED) |
| Registered Start Date | 2026-09-21 |
| WhyStopped Classification | Not Stopped |
Search related sites and sponsors in the Interactive Directory, explore Immunology, Rheumatology, and Dermatology Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.